1-25 of 49 Products & Services
This kit is designed to assess binding and inhibition of human PCSK9 and LDLR, using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapetics using competition assays.
This is a replacement for AL3119.
1-23 of 23 Business Insights